# clm_6B0B3077A414

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_research_and_development  
value: 575,000,000 United States dollar  
valid_from: 2018-06-30  
valid_to: 2018-09-30  
published: 2019-07-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_41B5CF7870D0  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly research and development: 575,000,000 United States dollar", as of 2018-06-30 (until 2018-09-30). Claim clm_6B0B3077A414, https://asof.is/claim/clm_6B0B3077A414, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000141057819000606/0001410578-19-000606-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-07-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000141057819000606/0001410578-19-000606-index.htm (primary, SEC EDGAR 10-Q Q2 FY2019, published 2019-07-31)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_research_and_development | 589,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_6B0B3077A414](/claim/clm_6B0B3077A414.md) | [clm_D0387CB879C0](/claim/clm_D0387CB879C0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.